Physician

John W Benson, MD

According to 2025 Medicare claims, John Benson, MD (NPI: 1205816287) practices family practice in the Mankato, MN market, with the plurality of this provider's patient population coming from Blue Earth, MN. This provider's primary affiliated billing organization is MANKATO CLINIC LTD (NPI: 1629044029; TIN: 410849339) and primary practice location at 56001-6076. Benson is affiliated with the Stratum Med ACO (ACO ID: A4527) and Mayo Clinic Community ACO, LLC (ACO ID: A4617), participating under the MSSP model.

Benson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,207 traditional Medicare patients, billed 10,653 HCPCS/CPT codes, and received $174,980 in Medicare payments. The top billing code was 88305 (Pathology examination of tissue using a microscope, intermediate complexity). Part D data shows 5,772 prescription claims across 482 beneficiaries totaling $546,350 in drug costs, led by Ozempic (Semaglutide). DME data shows 63 claims. Open Payments data shows 31 records totaling $260,660. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $66,338 to $174,980. Similarly, Part D prescription costs have risen steadily, from $363,719 to $546,350. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $8,779 and ending at $16,946.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	207	2,646	$66,338
2016	181	2,975	$58,057
2017	215	2,680	$59,828
2018	544	4,278	$78,963
2019	851	10,008	$128,148
2020	853	9,409	$116,909
2021	859	10,162	$146,578
2022	831	13,459	$139,853
2023	1,063	12,353	$163,123
2024	1,207	10,653	$174,980

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	374	4,881	$363,719
2016	369	4,941	$355,846
2017	380	5,072	$355,716
2018	377	5,064	$389,179
2019	409	5,181	$456,798
2020	434	5,582	$921,299
2021	460	5,308	$540,939
2022	482	5,553	$567,225
2023	465	5,789	$636,131
2024	482	5,772	$546,350

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	19	65	$1,363
2016	13	62	$5,821
2017	12	88	$9,525
2018	13	57	$8,722
2019	17	153	$16,034
2020	13	61	$10,007
2021	12	97	$10,399
2022	11	81	$11,858
2023	11	122	$16,576
2024	12	63	$15,940

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
88305	Pathology examination of tissue using a microscope, intermediate complexity	466	800	$24
80061	Blood test, lipids (cholesterol and triglycerides)	216	232	$13
80053	Blood test, comprehensive group of blood chemicals	332	431	$10
36415	Insertion of needle into vein for collection of blood sample	561	1,138	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	233	1,227	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	61	2,100	$66,543
Eliquis	Apixaban	47	3,203	$59,035
Xarelto	Rivaroxaban	32	2,460	$43,683
Jardiance	Empagliflozin	61	2,016	$39,963
Farxiga	Dapagliflozin Propanediol	26	1,296	$23,575

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	27	$12,505
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	13	$2,879
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	12	23	$556

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$239	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	19	$260,422	ModernaTX, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John W. Benson, MD?

Tedicare shows public-source Medicare data for John W. Benson, MD (NPI 1205816287), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John W. Benson, MD have ACO affiliation data?

John W. Benson, MD is shown with ACO affiliation data for Stratum Med ACO (MSSP, ACO ID A4527) and Mayo Clinic Community ACO, LLC (MSSP, ACO ID A4617).

What billing organization is linked to John W. Benson, MD?

John W. Benson, MD is linked to MANKATO CLINIC LTD (billing NPI 1629044029) in the available physician profile data.

Does John W. Benson, MD have Open Payments data?

John W. Benson, MD has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.